Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1982 Dec;14(6):769–778. doi: 10.1111/j.1365-2125.1982.tb02035.x

Pharmacokinetics of theophylline: a dose-range study.

V Rovei, F Chanoine, M Strolin Benedetti
PMCID: PMC1427546  PMID: 7150456

Abstract

1 Pharmacokinetics of theophylline were investigated in a group of healthy adult volunteers (non smokers and on xanthine-free diet) following single oral administration of 125, 250, 375 and 500 mg doses as tablets (Theodel). 2 Absorption of theophylline was rapid and followed first-order kinetics. Plasma curves were fitted according to a one compartment open model. 3 There was a linear relationship (P less than 0.001) between plasma Cmax or AUCx values and the administered dose. The analysis of variance showed that the pharmacokinetic parameters of theophylline (t1/2 abs, tmax, t1/2 beta, CL, CLR, Vd and F) were not modified at any dose. 4 Absorption of the drug was complete since the recovery in urine of theophylline (13.7 to 16.8% of the dose) and its major metabolites, 1,3-dimethyluric acid (35 to 42%), 1-methyluric acid (21.3 to 26.7%) and 3-methylxanthine (11.5 to 13.7%), accounted for the administered dose. Some impairment of demethylation to 3-methylxanthine was observed in two subjects, however the percentage of theophylline and its major metabolites excreted in urine was constant for all the four doses. 5 On the basis of these results, after single oral administration, elimination of theophylline followed first-order kinetics in the range of doses investigated (1.62 to 10.42 mg/kg).

Full text

PDF
769

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chrzanowski F. A., Niebergall P. J., Mayock R. L., Taubin J. M., Sugita E. T. Kinetics of intravenous theophylline. Clin Pharmacol Ther. 1977 Aug;22(2):188–195. doi: 10.1002/cpt1977222188. [DOI] [PubMed] [Google Scholar]
  2. Feldman C. H., Hutchinson V. E., Pippenger C. E., Blumenfeld T. A., Feldman B. R., Davis W. J. Effect of dietary protein and carbohydrate on theophylline metabolism in children. Pediatrics. 1980 Dec;66(6):956–962. [PubMed] [Google Scholar]
  3. Gomeni C., Gomeni R. IGPHARM: interactive graphic package for pharmacokinetic analysis. Comput Biomed Res. 1978 Aug;11(4):345–361. doi: 10.1016/0010-4809(78)90017-4. [DOI] [PubMed] [Google Scholar]
  4. Grygiel J. J., Birkett D. J. Effect of age on patterns of theophylline metabolism. Clin Pharmacol Ther. 1980 Oct;28(4):456–462. doi: 10.1038/clpt.1980.188. [DOI] [PubMed] [Google Scholar]
  5. Grygiel J. J., Wing L. M., Farkas J., Birkett D. J. Effects of allopurinol on theophylline metabolism and clearance. Clin Pharmacol Ther. 1979 Nov;26(5):660–667. doi: 10.1002/cpt1979265660. [DOI] [PubMed] [Google Scholar]
  6. Hendeles L., Weinberger M., Johnson G. Monitoring serum theophylline levels. Clin Pharmacokinet. 1978 Jul-Aug;3(4):294–312. doi: 10.2165/00003088-197803040-00003. [DOI] [PubMed] [Google Scholar]
  7. Jacobs M. H., Senior R. M., Kessler G. Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicity. JAMA. 1976 May 3;235(18):1983–1986. doi: 10.1001/jama.235.18.1983. [DOI] [PubMed] [Google Scholar]
  8. Jenne J. W., Nagasawa H. T., Thompson R. D. Relationship of urinary metabolites of theophylline to serum theophylline levels. Clin Pharmacol Ther. 1976 Mar;19(3):375–381. doi: 10.1002/cpt1976193375. [DOI] [PubMed] [Google Scholar]
  9. Jenne J. W., Wyze M. S., Rood F. S., MacDonald F. M. Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline. Clin Pharmacol Ther. 1972 May-Jun;13(3):349–360. doi: 10.1002/cpt1972133349. [DOI] [PubMed] [Google Scholar]
  10. Jonkman J. H., Tang D., Upton R. A., Riegelman S. Measurement of excretion characteristics of theophylline and its major metabolites. Eur J Clin Pharmacol. 1981;20(6):435–441. doi: 10.1007/BF00542096. [DOI] [PubMed] [Google Scholar]
  11. Jusko W. J., Gardner M. J., Mangione A., Schentag J. J., Koup J. R., Vance J. W. Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol. J Pharm Sci. 1979 Nov;68(11):1358–1366. doi: 10.1002/jps.2600681106. [DOI] [PubMed] [Google Scholar]
  12. Kappas A., Alvares A. P., Anderson K. E., Pantuck E. J., Pantuck C. B., Chang R., Conney A. H. Effect of charcoal-broiled beef on antipyrine and theophylline metabolism. Clin Pharmacol Ther. 1978 Apr;23(4):445–450. doi: 10.1002/cpt1978234445. [DOI] [PubMed] [Google Scholar]
  13. Koëter G. H., Jonkman J. H., de Vries K., Schoenmaker R., Greving J. E., de Zeeuw R. A. Pharmacokinetics of sustained release theophylline in low and high multidose regimens. Br J Clin Pharmacol. 1981 Nov;12(5):647–651. doi: 10.1111/j.1365-2125.1981.tb01283.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lesko L. J. Dose-dependent elimination kinetics of theophylline. Clin Pharmacokinet. 1979 Nov-Dec;4(6):449–459. doi: 10.2165/00003088-197904060-00004. [DOI] [PubMed] [Google Scholar]
  15. Levy G., Koysooko R. Pharmacokinetic analysis of the effect of theophylline on pulmonary function in asthmatic children. J Pediatr. 1975 May;86(5):789–793. doi: 10.1016/s0022-3476(75)80374-x. [DOI] [PubMed] [Google Scholar]
  16. Levy G., Koysooko R. Renal clearance of theophylline in man. J Clin Pharmacol. 1976 Jul;16(7):329–332. doi: 10.1002/j.1552-4604.1976.tb01528.x. [DOI] [PubMed] [Google Scholar]
  17. Lohmann S. M., Miech R. P. Theophylline metabolism by the rat liver microsomal system. J Pharmacol Exp Ther. 1976 Jan;196(1):213–225. [PubMed] [Google Scholar]
  18. Mitenko P. A., Ogilvie R. I. Pharmacokinetics of intravenous theophylline. Clin Pharmacol Ther. 1973 Jul-Aug;14(4):509–513. doi: 10.1002/cpt1973144part1509. [DOI] [PubMed] [Google Scholar]
  19. Mitenko P. A., Ogilvie R. I. Rational intravenous doses of theophylline. N Engl J Med. 1973 Sep 20;289(12):600–603. doi: 10.1056/NEJM197309202891202. [DOI] [PubMed] [Google Scholar]
  20. Monks T. J., Caldwell J., Smith R. L. Influence of methylxanthine-containing foods on theophylline metabolism and kinetics. Clin Pharmacol Ther. 1979 Oct;26(4):513–524. doi: 10.1002/cpt1979264513. [DOI] [PubMed] [Google Scholar]
  21. Muir K. T., Jonkman J. H., Tang D. S., Kunitani M., Riegelman S. Simultaneous determinations by theophylline and its major metabolites in urine by reversed-phase ion-pair high-performance liquid chromatography. J Chromatogr. 1980 Nov 14;221(1):85–95. doi: 10.1016/s0378-4347(00)81010-5. [DOI] [PubMed] [Google Scholar]
  22. Ogilvie R. I. Clinical pharmacokinetics of theophylline. Clin Pharmacokinet. 1978 Jul-Aug;3(4):267–293. doi: 10.2165/00003088-197803040-00002. [DOI] [PubMed] [Google Scholar]
  23. Ogilvie R. I. Monitoring plasma theophylline concentrations. Ther Drug Monit. 1980;2(2):111–117. doi: 10.1097/00007691-198004000-00001. [DOI] [PubMed] [Google Scholar]
  24. Pierson R. N., Jr, Lin D. H., Phillips R. A. Total-body potassium in health: effects of age, sex, height, and fat. Am J Physiol. 1974 Jan;226(1):206–212. doi: 10.1152/ajplegacy.1974.226.1.206. [DOI] [PubMed] [Google Scholar]
  25. Sarrazin E., Hendeles L., Weinberger M., Muir K., Riegelman S. Dose-dependent kinetics for theophylline: observations among ambulatory asthmatic children. J Pediatr. 1980 Nov;97(5):825–828. doi: 10.1016/s0022-3476(80)80280-0. [DOI] [PubMed] [Google Scholar]
  26. Staib A. H., Schuppan D., Lissner R., Zilly W., von Bomhard G., Richter E. Pharmacokinetics and metabolism of theophylline in patients with liver diseases. Int J Clin Pharmacol Ther Toxicol. 1980 Nov;18(11):500–502. [PubMed] [Google Scholar]
  27. Tang-Liu D. D., Williams R. L., Riegelman S. Nonlinear theophylline elimination. Clin Pharmacol Ther. 1982 Mar;31(3):358–369. doi: 10.1038/clpt.1982.46. [DOI] [PubMed] [Google Scholar]
  28. Upton R. A., Sansom L., Guentert T. W., Powell J. R., Thiercelin J. F., Shah V. P., Coates P. E., Riegelman S. Evaluation of the absorption from 15 commercial theophylline products indicating deficiencies in currently applied bioavailability criteria. J Pharmacokinet Biopharm. 1980 Jun;8(3):229–242. doi: 10.1007/BF01059644. [DOI] [PubMed] [Google Scholar]
  29. Weinberger M., Ginchansky E. Dose-dependent kinetics of theophylline disposition in asthmatic children. J Pediatr. 1977 Nov;91(5):820–824. doi: 10.1016/s0022-3476(77)81051-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES